After complaints from various organizations, the Food and Drug Administration has done an about-face and opened up bidding on a $4.25 million contract that was already earmarked for a health policy institute at Duke University run by former FDA commissioner Mark McClellan.
The decision is an unusual development that comes amid accusations of favoritism and confusion over the agency’s bidding process for certain types of grants.
About the Author Reprints
